<unk> (oral) is an antipsychotic agent that is FDA approved for the treatment of schizophrenia, bipolar I disorder (acute mixed or manic episodes and maintenance treatment as an adjunct to lithium or valproate), and acute treatment of agitation in schizophrenia. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include somnolence, respiratory tract infection, extrapyramidal symptoms, dizziness, akathisia, abnormal vision, asthenia, vomiting, nausea, and headache.
Ziprasidone 
Dapiprazole
Domperidone
Risperidone 
Paliperidone 
Clozapine
Aripiprazole 
Terizidone